Bajaj Healthcare has applied for a compulsory license against Eli Lilly for Baricitinib, citing affordability concerns. The post also covers the EPO’s decision on double patenting, updates from the IP5 meeting on AI patents, and new initiatives by WHO, WTO, and WIPO.
Read more about After Natco, Bajaj Healthcare files compulsory license against Eli Lilly; EPO Enlarged Board of Appeal issues decision on ‘double patenting’ and moreTag: IP5
WIPO gears up to appoint its 5th Director General, IP5 discuss New Emerging Technologies and Artificial Intelligence and other patent news
The article presents key patent news, including WIPO’s forthcoming Director General appointment and IP5’s focus on emerging technologies and AI. It also reviews major patent disputes, industry collaborations, and recent developments in global patent activity.
Read more about WIPO gears up to appoint its 5th Director General, IP5 discuss New Emerging Technologies and Artificial Intelligence and other patent news3M settles patent infringement suit, IP5 launch AI taskforce, EPO online courses and more
The bulletin reports on 3M’s patent infringement settlement, Indian and international patent statistics, the IP5 AI taskforce, and EPO’s new online courses. Key industry developments and IP initiatives are also discussed.
Read more about 3M settles patent infringement suit, IP5 launch AI taskforce, EPO online courses and more